0000897069-14-000500.txt : 20141230 0000897069-14-000500.hdr.sgml : 20141230 20141230114639 ACCESSION NUMBER: 0000897069-14-000500 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141230 DATE AS OF CHANGE: 20141230 EFFECTIVENESS DATE: 20141230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncolinx Pharmaceuticals, LLC CENTRAL INDEX KEY: 0001627422 IRS NUMBER: 465233317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-231043 FILM NUMBER: 141315028 BUSINESS ADDRESS: STREET 1: 716 MADISON STREET STREET 2: APT. 101 CITY: HOBOKEN STATE: NJ ZIP: 07030 BUSINESS PHONE: (848) 391-9367 MAIL ADDRESS: STREET 1: 716 MADISON STREET STREET 2: APT. 101 CITY: HOBOKEN STATE: NJ ZIP: 07030 FORMER COMPANY: FORMER CONFORMED NAME: Oncolinx Inc. DATE OF NAME CHANGE: 20141209 D 1 primary_doc.xml X0707 D LIVE 0001627422 Oncolinx Pharmaceuticals, LLC MassChallenge, Attn: Oncolinx 21 Drydock Avenue, 6th Floor Boston MA MASSACHUSETTS 02210 (848) 391-9367 DELAWARE Oncolinx Inc. Limited Liability Company true 2014 Sourav Sinha MassChallenge, Attn: Oncolinx 21 Drydock Avenue, 6th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Director Promoter Riley Ennis MassChallenge, Attn: Oncolinx 21 Drydock Avenue, 6th Floor Boston MA MASSACHUSETTS 02110 Executive Officer Director Promoter Pharmaceuticals Decline to Disclose 06b false 2014-10-31 false true true true false 0 1000000 350000 650000 false 1 0 0 0 false Oncolinx Pharmaceuticals, LLC Sourav Sinha Sourav Sinha President 2014-12-30